Adding Oncolytic Virus to Immunotherapy for Advanced Melanoma is Found to be Cost Prohibitive (CME/CE)

(MedPage Today) -- Combination treatment does not extend life and has little clinical benefit, cost-analysis finds
Source: MedPage Today Public Health - Category: American Health Source Type: news